Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Byetta (Exenatide).

Author: Nit Dirr
Country: Sweden
Language: English (Spanish)
Genre: Environment
Published (Last): 2 February 2015
Pages: 79
PDF File Size: 11.1 Mb
ePub File Size: 3.85 Mb
ISBN: 858-6-33516-806-8
Downloads: 28676
Price: Free* [*Free Regsitration Required]
Uploader: Faegal

Use with caution in patients with renal transplantation or when initiating or escalating the dose in patients with moderate renal failure. Byetta package insert placebo-treated patients withdrew due to nausea or vomiting.

Official BYETTA® (exenatide) injection Healthcare Professional Website

Pxckage with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption. Tell your healthcare provider if you are pregnant or plan to become pregnant. The most frequently reported adverse reactions leading to withdrawal for Byetta-treated patients were nausea 5. Increased risk of hypoglycemia when used byetta package insert combination with a sulfonylurea SU or when used with a glucose-independent insulin secretagogues eg, meglitinides. Tell your healthcare provider if you have or had kidney problems or a kidney indert.

Drug Interactions Oral Medications: You may give other people a serious infection, or get a serious infection from them.

BYETTA has been associated with byetta package insert pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, based on postmarketing data. Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery.

FDA Internet Application Site (Accessdata) Error

All other trademarks are paxkage of their respective owners. Staying Active Learn how regular physical activity can help you manage type 2 diabetes. Byetta package insert used byetta package insert insulin, evaluate and consider reducing the insulin dose in patients at increased risk of hypoglycemia. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth.

Tell your healthcare provider if you have severe problems with your stomach, such as delayed emptying of your stomach gastroparesis or problems with digesting food. Go to Patient Site.

BYETTA is an injectable prescription medicine byetta package insert may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise. Write your html here Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, packagr with or without vomiting or is felt going from your abdomen through to your back.

No clinical studies establishing conclusive evidence of byetta package insert risk reduction with BYETTA or any other antidiabetic drug.

Patients may develop byetta package insert to exenatide. Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.

Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic packagee failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.

Welcome to!

Glucagon-like peptide-1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. Talk to your healthcare provider first if you are breastfeeding byetta package insert plan to breastfeed. Based on postmarketing data BYETTA has been associated with byetta package insert pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. AstraZeneca is not responsible for the privacy policy of any third-party websites. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis.

The Double B logo is a trademark of the AstraZeneca group of companies. Concurrent use with prandial insulin has not been studied and cannot be recommended.

BYETTA should not be used in people with type 1 diabetes byetta package insert people with diabetic ketoacidosis a condition caused by very high blood sugar. Use in pediatric patients is not recommended as safety and effectiveness have not been established.

Because exenatide byetta package insert commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients byetta package insert severe gastrointestinal disease eg gastroparesis. Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.

Should not be used btetta patients with severe renal impairment or end-stage renal disease. All other trademarks are property of their respective owners. Inserrt of a severe allergic reaction include severe rash or itching, swelling of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat. This site is intended for US Consumers.

Inflammation of the pancreas pancreatitis may happen, which may be severe and byetta package insert to death. Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed.